TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 84 filers reported holding TCR2 THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $97,000 | -45.2% | 35,135 | -7.7% | 0.00% | – |
| Q4 2021 | $177,000 | -46.2% | 38,067 | -1.6% | 0.00% | – |
| Q3 2021 | $329,000 | -46.2% | 38,684 | +3.9% | 0.00% | -100.0% |
| Q2 2021 | $611,000 | -24.9% | 37,249 | +1.0% | 0.00% | 0.0% |
| Q1 2021 | $814,000 | -28.7% | 36,874 | -0.0% | 0.00% | -50.0% |
| Q4 2020 | $1,141,000 | +84.3% | 36,884 | +21.1% | 0.00% | +100.0% |
| Q3 2020 | $619,000 | +81.0% | 30,451 | +36.8% | 0.00% | 0.0% |
| Q2 2020 | $342,000 | +260.0% | 22,260 | +80.4% | 0.00% | – |
| Q1 2020 | $95,000 | -39.9% | 12,338 | +11.5% | 0.00% | – |
| Q4 2019 | $158,000 | -2.5% | 11,068 | +2.6% | 0.00% | – |
| Q3 2019 | $162,000 | – | 10,790 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 6,741,964 | $208,528,000 | 18.01% |
| MPM ASSET MANAGEMENT LLC | 4,050,865 | $125,293,000 | 17.73% |
| Consonance Capital Management LP | 584,885 | $71,268,000 | 6.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 136,000 | $4,206,000 | 2.44% |
| Redmile Group, LLC | 2,832,888 | $87,621,000 | 1.06% |
| Altium Capital Management LP | 73,991 | $2,289,000 | 0.86% |
| PFM Health Sciences, LP | 775,794 | $23,995,000 | 0.84% |
| Soleus Capital Management, L.P. | 199,867 | $6,182,000 | 0.82% |
| MOODY ALDRICH PARTNERS LLC | 123,639 | $3,824,000 | 0.62% |
| Sofinnova Investments, Inc. | 333,707 | $10,322,000 | 0.61% |